Skip to main content
Equibles

ALPS ADVISORS INC

Position in IDYA — IDEAYA Biosciences, Inc.

CIK 1376113 Denver, CO
Back to IDYA Full portfolio

Position in IDYA

as of Jun 30, 2026 · filed Jul 29, 2026
Position Value
$3,308,420
+$926,474 QoQ
Shares Held
88,769
+24.2% QoQ
Ownership
0.092%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#90
of 286 holders
Holding Since
Jun 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IDYA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ALPS ADVISORS INC holds $213,436,831 across 115 Biotechnology names. IDYA ranks #18 (1.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 315,335 $17,680,833
2 APGE
Apogee Therapeutics, Inc.
 62,523 $8,298,677
3 CGON
CG Oncology, Inc.
 89,218 $6,338,938
4 XENE
Xenon Pharmaceuticals Inc.
 97,610 $5,891,739
5 ORKA
Oruka Therapeutics, Inc.
 61,014 $5,806,702
6 DNTH
Dianthus Therapeutics, Inc. /DE/
 55,281 $5,388,791
7 TVTX
Travere Therapeutics, Inc.
 93,981 $5,339,060
8 DFTX
Definium Therapeutics, Inc.
 110,388 $5,192,651

All Filings in IDYA

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,308,420 88,769
2026-03-31 $2,381,946 71,487
2025-12-31 $2,481,745 71,789
2025-09-30 $1,146,901 42,150
2025-06-30 $993,047 47,243
2025-03-31 $1,007,992 61,538
2024-12-31 $1,796,224 69,892
2024-09-30 $2,055,715 64,890
2024-06-30 $2,073,315 59,052
2024-03-31 $2,280,926 51,981
2023-12-31 $1,510,371 42,450
2023-09-30 $1,146,083 42,479
2023-06-30 $989,608 42,111
2022-09-30 $319,422 21,409
2022-06-30 $316,365 22,925